Demerits of Remdesivir: An Unseen Trouble

Authors

  • Sundus Nasim Undergraduate Student (MBBS), Dow University of Health Sciences, Karachi, Sindh State, Pakistan
  • Sohail Kumar Undergraduate Student (MBBS), Dow University of Health Sciences, Karachi, Sindh State, Pakistan
  • Dua Azim Undergraduate Student (MBBS), Dow University of Health Sciences, Karachi, Sindh State, Pakistan
  • Areej Haider Hashmi Undergraduate Student, Bachelor of Arts (BA) in Global Public Health, University of Virginia College of Arts and Sciences, USA
  • Muhammad Taha Nasim A-levels Student, Karachi Grammar School (College Section), Karachi, Sindh State, Pakistan

DOI:

https://doi.org/10.3329/bjid.v7i00.50167

Keywords:

Antiviral; remdesivir; COVID-19; drug; pandemic

Abstract

Remdesivir is an investigational antiviral agent available for COVID-19 therapy. Even though its efficacy has been proven through various clinical trials, the evidence is still scarce. The side effects of remdesivir are highlighted in this paper and should be kept in mind during its use. Moreover, the availability of this drug is limited, and we fear an impending shortage of the said medicine in the near future. Thus through this letter we hope to increase awareness regarding this potentially lifesaving medicine.

Bangladesh Journal of Infectious Diseases, October 2020;7(suppl_2):S67-S68

Downloads

Download data is not yet available.
Abstract
435
PDF
251

Downloads

Published

2020-11-08

How to Cite

Nasim, S., Kumar, S., Azim, D., Hashmi, A. H., & Nasim, M. T. (2020). Demerits of Remdesivir: An Unseen Trouble. Bangladesh Journal of Infectious Diseases, 7(00), S67-S68. https://doi.org/10.3329/bjid.v7i00.50167

Issue

Vol 7, Supplementary Issue-2 (2020): Pandemic COVID19

Section

Perspective

License

Copyright

Copyright on any research article in the Bangladesh Journal of Infectious Diseases is retained by the author(s).

The authors grant the Bangladesh Infection Research Association a license to publish the article and identify itself as the original publisher.

Articles in the Bangladesh Journal of Infectious Diseases are Open Access articles published under the Creative Commons CC BY-NC License (https://creativecommons.org/licenses/by-nc/4.0/)

This license permits use, distribution and reproduction in any medium, provided the original work is properly cited, and it is not used for commercial purposes.